Text Size

Neuroprotection in neurodegenerations of the brain and eye: Lessons from the past and directions for the future

Levin, L .A.; Patrick, C.; Choudry, N.B.; Sharif, N.A.; Goldberg, J.L.


  • 2022
  • Front Neurol
View publication
  • Therapeutic Area

    Back of the eye (BOTE)

  • Categories

    Clinical development

  • Affiliations

    Departments of Ophthalmology and Visual Sciences, Neurology & Neurosurgery, McGill University, Montreal, QC, Canada. TELUS Health, Ottawa, ON, Canada; Global Alliances and External Research, Ophthalmology Innovation Center, Santen Inc., Emeryville, CA, United States; Spencer Center for Vision Research, Byers Eye Institute, Stanford University, Palo Alto, CA, United States

Related Publications

Functional significance of commonly regulated genes in mechanically and chemically induced retinal ganglion cell death in rat eyes

Kageyama M, Ohashi K, Ota T.


Valosin-containing protein modulator KUS121 protects retinal neurons in a rat model of anterior ischemic optic neuropathy

Kikkawa C., Ikeda H.O., Hata M., Iwai S., Tsujikawa A.


Rapid and efficient generation of mature retinal organoids derived from human pluripotent stem cells via optimized pharmacological modulation of Sonic hedgehog, activin A, and retinoic acid signal transduction

Matsushita T.; Onishi A.; Matsuyama T.; Masuda T.; Ogino Y.; Kageyama M.; Takahashi M.; Uchiumi F.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022